BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8287894)

  • 1. Chronic antidepressant drug treatment attenuates motor-suppressant effects of apomorphine without changing [3H]GBR 12935 binding.
    Allison K; Paetsch PR; Baker GB; Greenshaw AJ
    Eur J Pharmacol; 1993 Nov; 249(2):125-31. PubMed ID: 8287894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioural response to SKF 38393 and quinpirole following chronic antidepressant treatment.
    Allison K; Ivanová S; Greenshaw AJ
    Eur J Pharmacol; 1995 Apr; 277(2-3):139-44. PubMed ID: 7493601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of chronic antidepressant treatment on dopamine-related [3H]SCH 23390 and [3H]spiperone binding in the rat striatum.
    Paetsch PR; Greenshaw AJ
    Cell Mol Neurobiol; 1992 Dec; 12(6):597-606. PubMed ID: 1490276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-adrenoceptors and antidepressants: possible 2-phenylethylamine mediation of chronic phenelzine effects.
    McManus DJ; Mousseau DD; Paetsch PR; Wishart TB; Greenshaw AJ
    Biol Psychiatry; 1991 Dec; 30(11):1122-30. PubMed ID: 1663791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic administration of the antidepressants phenelzine, desipramine, clomipramine, or maprotiline decreases binding to 5-hydroxytryptamine2A receptors without affecting benzodiazepine binding sites in rat brain.
    Todd KG; McManus DJ; Baker GB
    Cell Mol Neurobiol; 1995 Jun; 15(3):361-70. PubMed ID: 7553735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of the tricyclic antidepressants on the apomorphine induced hypermotility in rats.
    Grabowska M; Antikiewicz L; Michaluk J
    Pol J Pharmacol Pharm; 1974; 26(4):411-7. PubMed ID: 4416321
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of age and of chronic antidepressant treatment on [3H]tryptamine and [3H]dihydroalprenolol binding to rat cortical membranes.
    Mousseau DD; McManus DJ; Baker GB; Juorio AV; Dewhurst WG; Greenshaw AJ
    Cell Mol Neurobiol; 1993 Feb; 13(1):3-13. PubMed ID: 8384528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioural evidence for supersensitivity of postsynaptic dopamine receptors in the mesolimbic system after chronic administration of desipramine.
    Spyraki C; Fibiger HC
    Eur J Pharmacol; 1981 Sep; 74(2-3):195-206. PubMed ID: 7198991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of a non-selective monoamine oxidase inhibitor, phenelzine, with inhibitors of 5-hydroxytryptamine, dopamine or noradrenaline re-uptake.
    Marley E; Wozniak KM
    J Psychiatr Res; 1984; 18(2):173-89. PubMed ID: 6747915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of chronic administration of antidepressants on the circadian pattern of corticosterone in the rat.
    Gómez F; Graugés P; Martín M; Armario A
    Psychopharmacology (Berl); 1998 Nov; 140(2):127-34. PubMed ID: 9860102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of chronic variable stress and antidepressant drugs on behavioral inactivity during an uncontrollable stress: interaction between both treatments.
    Murua VS; Molina VA
    Behav Neural Biol; 1992 Jan; 57(1):87-9. PubMed ID: 1567336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic administration of the antidepressant-antipanic drug phenelzine and its N-acetylated analogue: effects on monoamine oxidase, biogenic amines, and alpha 2-adrenoreceptor function.
    McKenna KF; Baker GB; Coutts RT; Greenshaw AJ
    J Pharm Sci; 1992 Aug; 81(8):832-5. PubMed ID: 1383493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of dopamine-mediated behavioural responses by antidepressants: effects of single and repeated treatment.
    Delini-Stula A; Vassout A
    Eur J Pharmacol; 1979 Oct; 58(4):443-51. PubMed ID: 574454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early postnatal antidepressant treatment and juvenile stereotyped behaviour in rats.
    Hilakivi I
    Eur J Pharmacol; 1994 Dec; 271(1):223-6. PubMed ID: 7698204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal exposure of rats to antidepressants enhances agonist affinity of brain dopamine receptors and dopamine-mediated behaviour.
    De Ceballos ML; Benedi A; De Felipe C; Del Rio J
    Eur J Pharmacol; 1985 Oct; 116(3):257-62. PubMed ID: 3841069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the participation of the dopaminergic system in the central effects of chronically administered antidepressant drugs.
    Kozyrska C; Zebrowska-Lupina I
    Pol J Pharmacol Pharm; 1983; 35(2):115-26. PubMed ID: 6684769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of functional down-regulation of beta-adrenoceptors in rats by 2-phenylethylamine.
    Paetsch PR; Baker GB; Greenshaw AJ
    J Pharm Sci; 1993 Jan; 82(1):22-4. PubMed ID: 8381487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time-dependent changes in sensitivity to apomorphine and monoamine receptors following withdrawal from continuous cocaine administration in rats.
    Neisewander JL; Lucki I; McGonigle P
    Synapse; 1994 Jan; 16(1):1-10. PubMed ID: 8134896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeated administration of fluoxetine, desipramine and tranylcypromine increases dopamine D2-like but not D1-like receptor function in the rat.
    Ainsworth K; Smith SE; Sharp T
    J Psychopharmacol; 1998; 12(3):252-7. PubMed ID: 10958251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors.
    Alemany R; Olmos G; García-Sevilla JA
    Br J Pharmacol; 1995 Feb; 114(4):837-45. PubMed ID: 7773544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.